AbstractIt is frequently argued that both amyloid beta (Aβ) and oxidative stress are involved in the pathogenesis of Alzheimer's disease (AD). We show here that clonal nerve cell lines and primary cortical neurons that are resistant to Aβ toxicity have an enhanced flux of glucose through both the glycolytic pathway and the hexose monophosphate shunt. AD brain also has increased enzymatic activities in both pathways relative to age-matched controls. The Aβ-induced changes in glucose metabolism are due to the activation of the transcription factor hypoxia inducible factor 1 (HIF-1). As a result of Aβ-induced changes in glucose metabolism, Aβ-resistant cells are more readily killed by glucose starvation and by classes of antipsychotic drugs th...
Alzheimer's disease (AD) is associated with peripheral metabolic disorders. Clinical/epidemiological...
AbstractAlzheimer disease (AD) is the most common form of dementia among the elderly and is characte...
Microvascular dysfunction is considered an integral part of Alzheimer disease (AD) pathogenesis, but...
AbstractIt is frequently argued that both amyloid beta (Aβ) and oxidative stress are involved in the...
Amyloid beta (Aβ) peptide accumulation in the brains of patients with Alzheimer's disease (AD) is cl...
Amyloid beta (Aβ) peptide accumulation in the brains of patients with Alzheimer\u27s disease (AD) is...
Synaptic degeneration and death of nerve cells are defining features of Alzheimer's disease (AD) and...
AbstractBrain glucose uptake/metabolism is impaired in Alzheimer disease (AD). Here, we report that ...
Alzheimer’s disease (AD) is characterized by deposition of the amyloid beta (Ab) peptide in the brai...
Alzheimer’s disease (AD) is the most common form of dementia, affecting more than 35 million people ...
Aß exerts prooxidant or antioxidant effects based on the metal ion concentrations that it sequesters...
Abnormal deposition of neuriticplaques is the uniqueneuropathological hallmark of Alzheimer's diseas...
Alzheimer's disease (AD) is associated with peripheral metabolic disorders. Clinical/epidemiological...
Amyloid β-peptide [Aβ(1-42)] is central to the pathogenesis of Alzheimer's disease (AD), and the AD ...
Alzheimer's disease (AD) is associated with peripheral metabolic disorders. Clinical/epidemiological...
Alzheimer's disease (AD) is associated with peripheral metabolic disorders. Clinical/epidemiological...
AbstractAlzheimer disease (AD) is the most common form of dementia among the elderly and is characte...
Microvascular dysfunction is considered an integral part of Alzheimer disease (AD) pathogenesis, but...
AbstractIt is frequently argued that both amyloid beta (Aβ) and oxidative stress are involved in the...
Amyloid beta (Aβ) peptide accumulation in the brains of patients with Alzheimer's disease (AD) is cl...
Amyloid beta (Aβ) peptide accumulation in the brains of patients with Alzheimer\u27s disease (AD) is...
Synaptic degeneration and death of nerve cells are defining features of Alzheimer's disease (AD) and...
AbstractBrain glucose uptake/metabolism is impaired in Alzheimer disease (AD). Here, we report that ...
Alzheimer’s disease (AD) is characterized by deposition of the amyloid beta (Ab) peptide in the brai...
Alzheimer’s disease (AD) is the most common form of dementia, affecting more than 35 million people ...
Aß exerts prooxidant or antioxidant effects based on the metal ion concentrations that it sequesters...
Abnormal deposition of neuriticplaques is the uniqueneuropathological hallmark of Alzheimer's diseas...
Alzheimer's disease (AD) is associated with peripheral metabolic disorders. Clinical/epidemiological...
Amyloid β-peptide [Aβ(1-42)] is central to the pathogenesis of Alzheimer's disease (AD), and the AD ...
Alzheimer's disease (AD) is associated with peripheral metabolic disorders. Clinical/epidemiological...
Alzheimer's disease (AD) is associated with peripheral metabolic disorders. Clinical/epidemiological...
AbstractAlzheimer disease (AD) is the most common form of dementia among the elderly and is characte...
Microvascular dysfunction is considered an integral part of Alzheimer disease (AD) pathogenesis, but...